Literature DB >> 29656376

Human Genetics of Sclerosing Bone Disorders.

Raphaël De Ridder1, Eveline Boudin1, Geert Mortier1, Wim Van Hul2.   

Abstract

PURPOSE OF REVIEW: The group of sclerosing bone disorders encompasses a variety of disorders all marked by increased bone mass. In this review, we give an overview of the genetic causes of this heterogeneous group of disorders and briefly touch upon the value of these findings for the development of novel therapeutic agents. RECENT
FINDINGS: Advances in the next-generation sequencing technologies are accelerating the molecular dissection of the pathogenic mechanisms underlying skeletal dysplasias. Throughout the years, the genetic cause of these disorders has been extensively studied which resulted in the identification of a variety of disease-causing genes and pathways that are involved in bone formation by osteoblasts, bone resorption by osteoclasts, or both processes. Due to this rapidly increasing knowledge, the insights into the regulatory mechanisms of bone metabolism are continuously improving resulting in the identification of novel therapeutic targets for disorders with reduced bone mass and increased bone fragility.

Entities:  

Keywords:  Craniotubular hyperostosis; Osteopetrosis; Paget’s disease of bone; Sclerosing bone disorders

Mesh:

Year:  2018        PMID: 29656376     DOI: 10.1007/s11914-018-0439-7

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  140 in total

1.  Defective signaling, osteoblastogenesis and bone remodeling in a mouse model of connexin 43 C-terminal truncation.

Authors:  Megan C Moorer; Carla Hebert; Ryan E Tomlinson; Shama R Iyer; Max Chason; Joseph P Stains
Journal:  J Cell Sci       Date:  2017-01-03       Impact factor: 5.285

2.  Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

Authors:  U Kornak; D Kasper; M R Bösl; E Kaiser; M Schweizer; A Schulz; W Friedrich; G Delling; T J Jentsch
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

3.  Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia.

Authors:  Su Jin Kim; Tadeusz Bieganski; Young Bae Sohn; Kazimierz Kozlowski; Mikhail Semënov; Nobuhiko Okamoto; Chi Hwa Kim; Ah-Ra Ko; Geung Hwan Ahn; Yoon-La Choi; Sung Won Park; Chang-Seok Ki; Ok-Hwa Kim; Gen Nishimura; Sheila Unger; Andrea Superti-Furga; Dong-Kyu Jin
Journal:  Hum Genet       Date:  2011-01-09       Impact factor: 4.132

4.  Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease.

Authors:  A Kinoshita; T Saito; H Tomita; Y Makita; K Yoshida; M Ghadami; K Yamada; S Kondo; S Ikegawa; G Nishimura; Y Fukushima; T Nakagomi; H Saito; T Sugimoto; M Kamegaya; K Hisa; J C Murray; N Taniguchi; N Niikawa; K Yoshiura
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone.

Authors:  Ricardo Usategui-Martín; Ismael Calero-Paniagua; Judith García-Aparicio; Luis Corral-Gudino; Javier Del Pino Montes; Rogelio González Sarmiento
Journal:  Genet Test Mol Biomarkers       Date:  2016-05-12

6.  Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.

Authors:  B D Gelb; G P Shi; H A Chapman; R J Desnick
Journal:  Science       Date:  1996-08-30       Impact factor: 47.728

7.  An SNX10 mutation causes malignant osteopetrosis of infancy.

Authors:  Memet Aker; Alex Rouvinski; Saar Hashavia; Asaf Ta-Shma; Avraham Shaag; Shamir Zenvirt; Shoshana Israel; Michael Weintraub; Albert Taraboulos; Zvi Bar-Shavit; Orly Elpeleg
Journal:  J Med Genet       Date:  2012-04       Impact factor: 6.318

8.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

9.  A boy with severe craniodiaphyseal dysplasia and apparently normal mother.

Authors:  Tadeusz Bieganski; Dobromila Baranska; Irmina Miastkowska; Artur Kobielski; Magdalena Gorska-Chrzastek; Kazimierz Kozlowski
Journal:  Am J Med Genet A       Date:  2007-10-15       Impact factor: 2.802

10.  Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.

Authors:  Michael B Major; Nathan D Camp; Jason D Berndt; Xianhua Yi; Seth J Goldenberg; Charlotte Hubbert; Travis L Biechele; Anne-Claude Gingras; Ning Zheng; Michael J Maccoss; Stephane Angers; Randall T Moon
Journal:  Science       Date:  2007-05-18       Impact factor: 47.728

View more
  5 in total

Review 1.  Camurati-Engelmann Disease.

Authors:  Wim Van Hul; Eveline Boudin; Filip M Vanhoenacker; Geert Mortier
Journal:  Calcif Tissue Int       Date:  2019-02-05       Impact factor: 4.333

Review 2.  The Endocrine Function of Osteocalcin Regulated by Bone Resorption: A Lesson from Reduced and Increased Bone Mass Diseases.

Authors:  Michela Rossi; Giulia Battafarano; Jessica Pepe; Salvatore Minisola; Andrea Del Fattore
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

3.  Genetic Analysis in a Familial Case With High Bone Mineral Density Suggests Additive Effects at Two Loci.

Authors:  Núria Martínez-Gil; Diana Ovejero; Natalia Garcia-Giralt; Carlos David Bruque; Leonardo Mellibovsky; Xavier Nogués; Raquel Rabionet; Daniel Grinberg; Susanna Balcells
Journal:  JBMR Plus       Date:  2022-02-18

Review 4.  The evolving therapeutic landscape of genetic skeletal disorders.

Authors:  Ataf Hussain Sabir; Trevor Cole
Journal:  Orphanet J Rare Dis       Date:  2019-12-30       Impact factor: 4.123

Review 5.  The Genetic Architecture of High Bone Mass.

Authors:  Celia L Gregson; Emma L Duncan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-29       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.